| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/21/2007 | USRE39793 Compositions for sorting polynucleotides |
| 08/21/2007 | CA2155947C Methods for in vivo delivery of biologics and compositions useful therefor |
| 08/16/2007 | WO2007091661A1 Sugar chain-modified liposome suitable for molecular imaging and utilization and production of the same |
| 08/16/2007 | WO2007090962A1 Preparation of poly(ethylene oxide)-coated nanoparticles of maghemite |
| 08/16/2007 | WO2006026020A3 Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
| 08/16/2007 | WO2005012489A3 Targeting endothelium for tissue-specific delivery of agents |
| 08/16/2007 | US20070190583 screening a breast cancer tumor to determine suitability for treatment with lapatinib; bioassay |
| 08/16/2007 | US20070190100 Engineering of material surfaces |
| 08/16/2007 | US20070189973 Contrast medium comprising liposomes containing hydrophobic chelate compound |
| 08/16/2007 | US20070189972 Method of forming nanobubbles |
| 08/16/2007 | US20070189971 Contrast Agents |
| 08/16/2007 | US20070189970 Contrast medium for thrombus formation |
| 08/16/2007 | US20070189969 Perfluoroalkyl-containing complexes, process for their production as well as their use |
| 08/16/2007 | US20070189968 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 08/16/2007 | US20070189967 a mixture of a benzofuran derivatives such as [2-(2-formyl-5-furanyl)-3-hydroxymethyl benzofuran], and a label selected from radioisotopes, paramagnetic particles and optical particles, used for in vivo and in vitro detection beta-amyloid in a sample of brain tissues; noninvasive medical diagnosis |
| 08/16/2007 | US20070189966 Diagnostic agents for pancreatic exocrine function |
| 08/16/2007 | US20070189963 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 08/16/2007 | DE102006001414A1 Nanokristalline Leuchtstoffe durch Mikrowellen-vermittelte Synthese in Ionischen Flüssigkeiten Nanocrystalline phosphors by microwave-assisted synthesis in ionic liquids |
| 08/15/2007 | EP1818054A1 Use of a gadolinium chelate for labeling cells |
| 08/15/2007 | EP1817098A1 Method and apparatus for the preparation of dispersions of particles for use as contrast agents in ultrasound imaging |
| 08/15/2007 | EP1817062A2 Radiation dosimetry and blocking antibodies and methods and uses threfor in the treatment of cancer |
| 08/15/2007 | EP1817061A2 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 08/15/2007 | EP1817011A2 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 08/15/2007 | EP1198254B1 Carrier-drug conjugate |
| 08/15/2007 | CN101019028A Compounds and methods for combined optical-ultrasound imaging |
| 08/15/2007 | CN101018568A Superparamagnetic gadolinium oxide nanoscale particles and compositions comprising such particles |
| 08/15/2007 | CN101015702A Lipid ultrasonic contrast freeze-drying agent and its preparing process |
| 08/15/2007 | CN101015701A In vivo reaction type micro air bubble ultrasonic contrast medium and its preparing process |
| 08/15/2007 | CN101015700A Building method of colorectal cancer neostomy orthotopic transplantation model |
| 08/14/2007 | US7256172 Administering to animal, an amount of a peptide effective for mediating relaxation of airway, peptide is capable of activating an airway epithelium protease activated receptor-2 (PAR2) under conditions sufficient for activation of said PAR2 to occur, thereby mediating relaxation of airway |
| 08/14/2007 | US7256047 Measurement of gluconeogenesis and intermediary metabolism using stable isotopes |
| 08/14/2007 | US7255875 Integrin targeted imaging agents |
| 08/14/2007 | US7255851 Non-invasive localization of a light-emitting conjugate in a mammal |
| 08/14/2007 | US7255850 The rates of the two arms of reverse cholesterol transport (HDL or first arm and post-HDL or second arm) are obtained by measuring the flow of unlabeled cholesterol from tissues into plasma HDL and from plasma HDL to bile acids |
| 08/09/2007 | WO2007090022A2 Novel compounds for targeting endothelial cells, compositions containing the same and methods for their use |
| 08/09/2007 | WO2007089911A2 Methods for detection of circulating tumor cells and methods of diagnosis of cancer in a mammalian subject |
| 08/09/2007 | WO2007088918A1 Food and process for producing food |
| 08/09/2007 | WO2007088129A2 Cyanine dye compounds linked to metal chelator for bi-modal diagnostic imaging |
| 08/09/2007 | US20070185311 Peptide-Based Multimeric Targeted Contrast Agents |
| 08/09/2007 | US20070185040 Guanidinium derivatives for improved cellular transport |
| 08/09/2007 | US20070184119 Surface modified protein microparticles |
| 08/09/2007 | US20070183978 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 08/09/2007 | US20070183977 RGD peptide sequence; labelled with fluorescein used as contrast agents in optical imaging in diagnosis of angiogenesis-related diseases; peptidic vector and the fluorescein dye are coupled; cyclic peptide forming disulife or monothioether bridge |
| 08/09/2007 | US20070183976 Composition for ultrasound therapy and pharmaceutical liquid composition containing the same |
| 08/09/2007 | US20070183975 Polypeptide absorbable into digestive organs |
| 08/09/2007 | US20070183974 Method and apparatus for production of a skin graft and the graft produced thereby |
| 08/09/2007 | US20070183970 Chimeric, human and humanized anti-granulocyte antibodies and methods of use |
| 08/09/2007 | DE102005033903B4 Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them |
| 08/08/2007 | EP1816475A1 Use of cyanine dyes for the diagnosis of disease associated with angiogenesis |
| 08/08/2007 | EP1816423A2 High volume hyperpolarizer for spin-polarized noble gas |
| 08/08/2007 | EP1815871A2 Radiographic contrasting agents and radio-opaque polymeric materials for medical devices |
| 08/08/2007 | EP1815870A1 Cyanine dye compounds linked to metal chelator for bi-modal diagnostic imaging |
| 08/08/2007 | EP1814876A2 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease |
| 08/08/2007 | EP1814650A1 Apparatus and method for the production of ultrasound contrasts agents |
| 08/08/2007 | EP1814598A2 Contrast agents to target extracellular matrix |
| 08/08/2007 | EP1814390A2 Methods of treating hematological malignancies with nucleoside analog drugs |
| 08/08/2007 | EP1742926B1 Macrocycle-substituted trimer halogen-benzol derivatives |
| 08/08/2007 | EP1587510A4 Method for treating ischemic stroke with melatonin |
| 08/08/2007 | EP1349962A4 Methods and compositions for detecting polynucleotide duplex damage |
| 08/08/2007 | EP0843516B1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
| 08/08/2007 | CN1330668C Antibodies to insulin-like growth factor I receptor |
| 08/08/2007 | CN1330380C X-ray contrast agent composition and its preparation method |
| 08/08/2007 | CN101014370A Gingko extract for curing neurotoxicity induced by therapeutic agent |
| 08/08/2007 | CN101012231A Isothiocyano fluorescein stearic amine grafting product and its synthetic method and application |
| 08/08/2007 | CN101011587A NMR contrast agent and preparation method thereof |
| 08/08/2007 | CN101011586A Diagnostic imaging contrast agents with extended blood retention |
| 08/08/2007 | CN101011585A Process for preparing non-alcohol fatty liver mouse model |
| 08/08/2007 | CN101011237A Pharmaceutical in vivo dynamics characteristic-nondestructive in situ monitoring system and monitoring method |
| 08/07/2007 | US7252821 Cancerous disease modifying antibodies |
| 08/07/2007 | US7252815 using carbocyanine dye; photodynamic therapy; supplying to tumor |
| 08/07/2007 | CA2365832C Pharmacological screening of neuronally active substances |
| 08/07/2007 | CA2332007C Adenosine a3 receptor modulators |
| 08/07/2007 | CA2301799C Novel conjugates of opioids and endogenous carriers |
| 08/07/2007 | CA2289088C Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
| 08/02/2007 | WO2007032876A3 Biomarkers associated with age-related macular degeneration |
| 08/02/2007 | WO2006131925A3 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 08/02/2007 | WO2005084329A3 Method for inhibiting tumor formation and growth |
| 08/02/2007 | US20070179556 Gastrointestinal methods and apparatus for use in treating disorders |
| 08/02/2007 | US20070179124 Substituted Porphyrins |
| 08/02/2007 | US20070178047 Drug carrier and ultrasound apparatus |
| 08/02/2007 | US20070178046 System for correlating odors and tastes to objective elements |
| 08/02/2007 | DE102006024245A1 Medizinisches Instrument und Verfahren zur Lokalisierung desselben im menschlichen Körper The medical instrument and method for locating the same in the human body |
| 08/02/2007 | DE102004054084B4 Stent mit einem Marker zur Verbesserung der Röntgensichtbarkeit, die Verwendung sowie ein Verfahren zum Herstellen eines derartigen Stents Stent with a marker in order to improve the radiopacity, the use of and a method of manufacturing such stents |
| 08/01/2007 | EP1812579A1 A non-human animal alzheimer's disease model and uses thereof |
| 08/01/2007 | EP1812101A2 Modeling of pharmaceutical propagation |
| 08/01/2007 | EP1812079A2 Pharmaceutical mixture evaluation |
| 08/01/2007 | EP1054625B1 Improvements in or relating to ultrasonography |
| 08/01/2007 | CN2928035Y Mouse ear marker |
| 08/01/2007 | CN101010107A Luminescent metal complexes for monitoring renal function |
| 07/31/2007 | US7250551 Inhibiting amyloid precursor protein phosphorylation; using kinase inhibitors; reducing, preventing and/or reversing Alzheimer's symptoms; transgenic mice, cell lines, assays |
| 07/31/2007 | US7250154 Radio-opaque polymeric biomaterials |
| 07/31/2007 | US7250153 Contrast media formulations having improved biological tolerance |
| 07/31/2007 | CA2247029C A process for the purification of opacifying contrast agents |
| 07/26/2007 | WO2007084532A2 Combination therapy with parp inhibitors |
| 07/26/2007 | WO2007083287A2 Test method for assessing irritation of skin |
| 07/26/2007 | WO2007083036A1 Novel lanthanide ligands and complexes, and use thereof as contrast agents |
| 07/26/2007 | WO2007053637A3 A tumor susceptible rat with a mutation in apc gene |
| 07/26/2007 | WO2007031777A3 Method of determining damage to skin |
| 07/26/2007 | WO2006057988A3 Use of endothelin etb receptor agonists and eta receptor antagonists in tumor imaging |
| 07/26/2007 | WO2006055447A3 Nanoparticles having a magnetic core and a cationic organo-silane coating for the delivery of oligonucleotides |